Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process

European Journal of Human Genetics

Volumn 21, Issue 10, 2013, Pages 1054-1059

  Ayuso, Carmen ^a,b   Millán, José M ^b,c   Mancheño, Marta ^d   Dal Ré, Rafael ^e  

^a 28400 Madrid   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^d HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^e Clinical Research Program   (Spain)

Author keywords

clinical setting; ethical issues; incidental findings; informed consent; whole exome sequencing; whole genome sequencing

Indexed keywords

ARTICLE; COCHRANE LIBRARY; CONFIDENTIALITY; EMBASE; GENE SEQUENCE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INCIDENTAL FINDING; INFORMED CONSENT; MEDICAL ETHICS; MEDLINE; PATIENT INFORMATION; PRIORITY JOURNAL; RISK; SYSTEMATIC REVIEW; WHOLE GENOME SEQUENCING;

GENETIC TESTING; GENOME, HUMAN; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; SEQUENCE ANALYSIS, DNA; STANDARD OF CARE;

EID: 84884587533     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.297     Document Type: Article

References (34)

1. Human Genome Project Information. http://www.ornl.gov/sci/techresources/ Human-Genome/home.shtml (accessed 20 June 2012).
2. National Human Genome Research Institutehttp://www.genome.gov/11006943 (accessed 20 June 2012).
3. Biesecker LG: Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: Lessons from the ClinSeq project. Genet Med 2012; 14: 393-398
4. Welch JS, Westerlvet P, Ding L et al: Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA 2011; 315: 1577-1584
5. Lunshof JE, Bobe J, Aach J et al: Personal genomes in progress: From the Human Genome Project to the Personal Genome Project. Dialogues Clin Neurosci 2010; 12: 47-60
6. Haga SB, Terry SF: Ensuring the safe use of genomic medicine in children. Clin Pediatr 2009; 48: 703-708
7. Foundation for Genomics and Population Health: Next steps in the sequence, the implications of whole genome sequencing for health in the UK. PHG Foundation: Cambridge, MA, 2011; http://www.phgfoundation.org/reports/10364/ (accessed 20 June 2012).
8. Ku Ch-S, Wu M, Cooper DN et al: Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis. Expert Rev. Mol. Diagn 2012; 12: 159-173
9. Christenhusz GM, Decriendt K, Dierickx K: To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts. Eur J Hum Genet 2012; 21: 248-255
10. Asociacio'n Espan? ola de Gené tica Humana. Consentimiento informado para la realizacio ́n de pruebas diagno'sticas. http://aegh.org/images/cidiagnostico.pdf (accessed 20 June 2012).
11. British Society for Human Genetics. Consent and Confidentiality in Genetic Practice: Guidance on Genetic Testing and Sharing Genetic Information; Report of the Joint Committee on Medical Genetics 2006. http://www.bshg.org.uk/ documents/official-docs/consent-pages-web.pdf (accessed 20 June 2012)
12. Swiss Society of Medical Genetics Informed choice in diagnostic genetic testing 2007; http://www.sgmg.ch/user-files/images/ Einverst%C3%A4ndniserkl%C3%A4rung%20 SGMG%20erg%C3%A4nzt%20E%202007.pdf (accessed 20 June 2012).
13. Ali-Khan SE, Daar AS, Shuman C, Ray PN, Scherer SW: Whole genome scanning: Resolving clinical diagnosis and management amidst complex data. Pediatr Res 2009; 66: 357-363
14. Netzer C, Klein C, Kohlhase J et al: New challenges for informed consent through whole genome array testing. J Med Genet 2009; 46: 495-496
15. Ormond KE, Wheeler MT, Hudgins L et al: Challenges in the Clinical application of whole-genome sequencing. Lancet 2010; 375: 1749-1751
16. Ransohoff DF, Khoury MJ: Personal genomics: Information can be harmful. Eur J Clin Invest 2010; 40: 64-68
17. Sharp RR: Downsizing genomic medicine: Approaching the ethical complexity of whole-genome sequencing by starting small. Genet Med 2011; 13: 191-194
18. Sijmons RH, Van Langen IM, Sijmons JG: A clinical perspective on ethical issues in genetic testing. Account Res 2011; 18: 148-162
19. Raffan E, Semple RK: Next generation sequencing - implications for clinical practice. British Med Bull 2011; 99: 53-71
20. Berg JS, Khoury MJ, Evans JP: Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet Med 2011; 113: 499-504
21. Green RC, Berg JS, Berry GT et al: Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med 2012; 14: 405-410
22. Hastings R, De Wert G, Fowler B et al: The changing landscape of genetic testing and its impact on clinical and laboratory services and research in Europe. Eur J Hum Genet 2012; 20: 911-916
23. Thorogood A, Knoppers BM, Dondorp WJ: Whole-genome sequencing and the physician. Clin Genet 2012; 81: 511-513
24. Organisation for Economic Co-operation and Development: OECD guidelines for quality assurance in molecular genetic testing 2007; http://www.oecd.org/ dataoecd/43/6/38839788.pdf (accessed 20 June 2012).
25. Eurogentest: Recommendations for genetic counselling related to genetic testing 2008; http://www.eurogentest.org/web/info/public/unit3/final- recommendations- genetic-counselling.xhtml (accessed 20 June 2012).
26. WMA Statement on Genetics and Medicine. Adopted by the 56th WMA General Assembly, Santiago, Chile, October 2005 and amended by the 60th WMA General Assembly, New Delhi, India, October 2009; http://www.wma.net/en/30publications/ 10policies/g11/(accessed 20 June, 2012).
27. Dondorp WJ, de Wert GM: The 'thousand-dollar genome': An ethical exploration, Monitoring Report Ethics and Health, 2010/2. The Hague: Centre for Ethics and Health 2010; http://www.gezondheidsraad.nl/en/publications/thousand- dollar-genomeethical- exploration (accessed 20 June 2012).
28. Human Genomes Strategy Group: Building on our inheritance, Genomic technology in healthcare. A report by the Human Genomics Strategy Group, January 2012; http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAnd Guidance/DH-132369 (accessed 20 June 2012).
29. American College of Medical Genetics and Genomics (ACMG): Policy Statement, Points to Consider in the Clinical Application of Genomic Sequencing, March 2012; http://www.acmg.net/StaticContent/PPG/Clinical-Application-of- Genomic- Sequencing.pdf (accessed 20 June 2012).
30. Dimmock D: A personal perspective on returning secondary results of clinical genome sequencing. Genome Med 2012; 4: 54
31. Bunnik EM, Schermer MH, Janssens AC: The role of disease characteristics in the ethical debate on personal genome testing. BMC Med Genom 2012; 5: 4
32. Macarthur DG: Challenges in clinical genomics. Genom Med 2012; 4: 43
33. Samuels ME, Orr A, Guernsey DL et al: Is gene discovery research or diagnosis? Genet Med 2008; 10: 385-390
34. Facio FM, Eidem H, Fisher T et al: Intentions to receive individual results from wholegenome sequencing among participants in the ClinSeq study. Eur J Hum Genet 2012; 21: 261-265